Outcomes: Five sets of outcomes will be assessed: (1) glycemic control (glycated blood proteins [HbA1c, fructosamine, glycated albumin], fasting glucose, and fasting insulin), (2) blood lipids (Established therapeutic lipid targets [LDL-cholesterol, non-HDL-cholesterol, apolipoprotein B (apo B), HDL-cholesterol, triglycerides]), (3) blood pressure (Systolic blood pressure and diastolic blood pressure), (4) uric acid, and (5) non-alcoholic fatty liver disease (NAFLD) (intrahepatocellular lipids [IHCL], alanine aminotransferase [ALT], aspartate aminotransferase [AST]).